Quantum Biopharma Ltd.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Jun 30, 2026 · Filed Aug 13, 2026

Use the contents to explore the available documents and sections.

QNTM$2.11-0.2%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Note:

Note:

1.	The Class A Multiple Voting Shares represent approximately 58,96% of the voting rights attached to Quantum’s outstanding voting securities.

As of the date of this MD&A, the Company had 8,087,479 Class B Subordinate Voting Shares issued and outstanding. The ownership was distributed as follows:

1.	7,155,616 Class B Subordinate Voting Shares, or 88.48%, were held through depository nominees (CEDE & Co. and CDS & Co.) on behalf of The Depository Trust & Clearing Corporation; and

2.	931,863 Class B Subordinate Voting Shares, or 11.52%, were held by registered holders with the Company’s transfer agent.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.